Metraipolis › archive › dc_c06addbdba7f

Impact of estroprogestin therapies on bone health from adolescence to postmenopause — Europe PMC PMID:41706416

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41706416
DOI: 10.1007/s40618-[numero omesso]-2
License (as archived): solo-consultazione
Archived: 2026-11-05T16:28:52.699Z
SHA-256 of the archived text: 6111eacc4b5479d31e51ee930c636745ab3fb5ad93a848922e508f761efe57a3
Stable URL of this page: https://metraipolis.com/documento/dc_c06addbdba7f

How to cite

Impact of estroprogestin therapies on bone health from adolescence to postmenopause — Europe PMC PMID:41706416 — Europe PMC (en), https://europepmc.org/article/MED/41706416 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c06addbdba7f (Metraipolis archive dc_c06addbdba7f, sha256 6111eacc4b5479d31e51ee930c636745ab3fb5ad93a848922e508f761efe57a3)

BibTeX

@misc{dcc06addbdba7f,
  title = {Impact of estroprogestin therapies on bone health from adolescence to postmenopause — Europe PMC PMID:41706416},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41706416},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c06addbdba7f; sha256 6111eacc4b5479d31e51ee930c636745ab3fb5ad93a848922e508f761efe57a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41706416. Agents can read the archived copy with the MCP tool read_document.